Email Us
The Trial Lawyer Magazine Logo
SUBSCRIBE

Litigation Growing in Byetta, Januvia, and Victoza Pancreatic Cancer MDL
Litigation Growing in Byetta, Januvia, and Victoza Pancreatic Cancer MDL

Roopal Luhana Jul 17, 2018 In December 2017, a federal appeals court reinstated nearly 700 type 2 diabetes medication lawsuits that had previously been dismissed, allowing the cases to move forward because of new evidence that supported the plaintiffs’ claims. The plaintiffs claim that medications like Byetta, Januvia, and Victoza lead to serious injuries, including pancreatic cancer.

Read the source article at New York Personal Injury Lawyer

Generic selectors
Exact matches only
Search in title
Search in content
The Trial Lawyer Magazine Logo
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram